ResMed Inc.  

(Public, NYSE:RMD)   Watch this stock  
Find more results for resmed
69.03
+0.59 (0.86%)
Aug 26 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 68.51 - 69.28
52 week 49.11 - 70.90
Open 68.74
Vol / Avg. 1.06M/957,294.00
Mkt cap 9.80B
P/E 27.72
Div/yield 0.33/1.91
EPS 2.49
Shares 140.70M
Beta 0.66
Inst. own 65%
Nov 17, 2016
ResMed Inc Annual Shareholders Meeting (Estimated) - 6:00PM EST - Add to calendar
Oct 20, 2016
Q1 2017 ResMed Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 28, 2016
Q4 2016 ResMed Inc Earnings Call
Jul 28, 2016
Q4 2016 ResMed Inc Earnings Release
Jun 14, 2016
ResMed Inc at William Blair Growth Stock Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2016
Net profit margin 17.94% 19.17%
Operating margin 22.87% 23.29%
EBITD margin - 28.43%
Return on average assets 13.08% 12.95%
Return on average equity 22.16% 21.47%
Employees 5,250 -
CDP Score - -

Address

9001 Spectrum Center Blvd
SAN DIEGO, CA 92123-1438
United States - Map
+1-858-7462400 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ResMed Inc. is a holding company. The Company, through its subsidiaries, designs, manufactures and markets equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. The Company develops a range of products for sleep-disordered breathing and other respiratory disorders, including airdevices, informatics solutions, diagnostic products, mask systems, headgear and other accessories. The Company owns interest in Inova Labs Inc., a medical device company specializing in the development and commercialization of oxygen therapy products. The Company holds interest in Brightree LLC, a provider of business management and clinical software applications for the post-acute care industry. The Company's manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States.

Officers and directors

Robert D. Douglas President, Chief Operating Officer
Age: 55
Bio & Compensation  - Reuters
Michael J. Farrell Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
Brett A. Sandercock Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Donald Darkin President – innovation & operations
Age: 62
Bio & Compensation  - Reuters
Jim Hollingshead Ph.D. President - Americas
Age: 52
Bio & Compensation  - Reuters
Anne Reiser President – Europe & Asia Pacific
Age: 54
Bio & Compensation  - Reuters
David Brian Pendarvis Chief Administrative Officer, Global General Counsel, Company Secretary
Age: 56
Bio & Compensation  - Reuters
Agnes Lee Senior Director - Investor Relations
Bio & Compensation  - Reuters
Peter C. Farrell Ph.D. Non-Executive Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Ronald R. Taylor Lead Independent Director
Age: 67
Bio & Compensation  - Reuters